ロード中...
Effect of edaravone therapy in Korean amyotrophic lateral sclerosis (ALS) patients
Oxidative stress caused by free radicals has been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS). Edaravone (also known as MCI-186), a free radical scavenger, was approved as an ALS treatment in 2015 in Japan. However, the therapeutic effects of edaravone on patients with ALS...
保存先:
| 出版年: | Neurol Sci |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7223963/ https://ncbi.nlm.nih.gov/pubmed/31471712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10072-019-04055-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|